Intellia Therapeutics (NTLA) Insider Trading & Ownership → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free NTLA Stock Alerts $22.72 -2.12 (-8.53%) (As of 05/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$1.37 M Get NTLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NTLA Insider Buying and Selling by Quarter Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. Intellia Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/4/2024James BastaEVPSell2,297$32.99$75,778.03 1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.25 1/3/2024David LebwohlEVPSell5,843$29.46$172,134.78 1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.90 1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58 10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.50 Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself8/25/2023Thomas R. CarperU.S. Congress Member (D-DE)Sell$38.25$1,001 - $15,0007/31/2023Muna BhanjiDirectorSell265$42.33$11,217.45 7/6/2023Muna BhanjiDirectorSell1,867$39.30$73,373.10 7/3/2023Eliana ClarkEVPSell360$40.51$14,583.60 6/20/2023Eliana ClarkEVPSell5,000$45.00$225,000.00 (Data available from 1/1/2013 forward) NTLA Insider Trading Activity - Frequently Asked Questions Who is on Intellia Therapeutics's Insider Roster? The list of insiders at Intellia Therapeutics includes David Lebwohl, Eliana Clark, Glenn Goddard, James Basta, Jean Francois Formela, John F Crowley, John M Leonard, Laura Sepp-Lorenzino, and Muna Bhanji. Learn more on insiders at NTLA. What percentage of Intellia Therapeutics stock is owned by insiders? 3.00% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings. Which Intellia Therapeutics insiders have been selling company stock? The following insiders have sold NTLA shares in the last 24 months: David Lebwohl ($172,134.78), Eliana Clark ($239,583.60), Glenn Goddard ($248,361.57), James Basta ($75,778.03), John M Leonard ($814,611.91), Laura Sepp-Lorenzino ($159,001.93), and Muna Bhanji ($90,924.05). How much insider selling is happening at Intellia Therapeutics? Insiders have sold a total of 54,368 Intellia Therapeutics shares in the last 24 months for a total of $1,800,395.87 sold. Which members of congress are trading Intellia Therapeutics? Thomas R. Carper (D-DE) has sold shares of Intellia Therapeutics in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: Celldex Therapeutics Insider Selling Myriad Genetics Insider Selling QuidelOrtho Insider Selling Neogen Insider Selling Editas Medicine Insider Selling CRISPR Therapeutics Insider Selling Sangamo Therapeutics Insider Selling Lantheus Insider Selling Janux Therapeutics Insider Selling MoonLake Immunotherapeutics Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:NTLA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsBitcoin’s Biggest Year YetParadigm PressThe #1 Crypto for AIWeiss RatingsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.